Evaxion Biotech picks candidate for lung cancer trial
A clinical-stage biotech company that specializes in developing AI-driven immunotherapies has chosen its product candidate…
June 23, 2022 - 2 minutes
Liza Laws
Osivax gets €10M influenza vaccine grant
A grant of €10 million ($10.5 million) has been secured by pharmaceutical company Osivax to…
June 23, 2022 - 2 minutes
Shanghai biotech secures $80 million to advance products
A bio-manufacturing company based in Shanghai has bagged $80 million in funding to advance its…
June 23, 2022 - 2 minutes
Roquefort Therapeutics buys UK biotech in return for shares
Medical biotechnology company, Roquefort Therapeutics, has conditionally agreed to buy UK biotech Oncogeni Ltd in…
June 22, 2022 - 2 minutes
Millions invested for progression of Lyme disease vaccine
Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. …
June 22, 2022 - 2 minutes
US Toddlers and children to receive Covid-19 vaccine after emergency approval granted
Emergency authorization was granted for the use of the Pfizer-BioNTech Covid-19 vaccines on children from…
June 22, 2022 - 3 minutes
Drug to treat esophageal cancer approved in China
A new drug application for first-line treatment of unresectable, locally advanced, recurrent or metastatic esophageal…
June 21, 2022 - 2 minutes
New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer
Data supporting the detection of minimal residual disease (MRD) has highlighted potential to provide an…
June 21, 2022 - 3 minutes
Treatment for highly-sensitized kidney transplant patients approved and recommended
Treatment offered by Hansa Biopharma for the densensitization of highly sensitized adults prior to kidney…
June 21, 2022 - 3 minutes
ImCheck raises €96M in funding round
French biotech company ImCheck has announced funding of €96 million ($101.5 million) to investigate antibody…
June 17, 2022 - 3 minutes
Taiwanese company sells knee pain drug for $30 million
A clinical stage pharma company specializing in developing nanomedicines will receive $30 million in exchange…
June 16, 2022 - 3 minutes
Spirea raises £2.4M to develop antibody drug conjugates in cancer
Funding of £2.4 million ($2.9 million) has been secured by UK-based company, Spirea Limited, to…
June 16, 2022 - 3 minutes
